Abstract Atherosclerosis is a pathologic disorder which has an important role in the occurrence of coronary heart disease. It is determined as a focal, inflammatory proliferative response to several types of endothelial damage. Apolipoprotein B which is a requirement in the sustenance of cholesterol homeostasis, and is the major protein component of low density lipoprotein, characterized by multitude polymorphic sites, one of which (12669G[A) is related to the levels of serum lipid profiles, coronary artery disease and/or myocardial infarction. One Common polymorphism which is more important in this process is 12669G[A that is appraised in this research. We recruited 80 patients from the Mousavi hospital, Zanjan, Iran, diagnosed with coronary artery disease by the clinician on the basis of clinical symptoms, echocardiogram result, and angiography. Seventy-seven healthy individuals without any evident symptoms of Coronary stenosis and any past history of the disease were taken as controls from the general population. We carried out PCR using specific primers. Then, we digested PCR product by RFLP. Lipid parameters by biochemical methods and Apolipoprotein B serum level by immunoturbidometry method were done. Genotype frequencies for 12669G[A polymorphism were determined: 55 % R?R?, 45 % R?R-in case group, and 55.8 R?R?, 44.2 % R?R-in controls. The R-Rgenotype was not seen. There was no significant relationship between this polymorphism and the risk of Coronary stenosis (P = 0.6). In the present study, higher plasma levels of cholesterol and low density lipoproteins in the subjects with R?R-genotype were found while there was no association between this polymorphism and coronary stenosis with C50 % in the Zanjan population.
Introduction
Atherosclerosis, as a chronic inflammatory disease originating from a state of disequilibrium in lipid metabolism and showing faulty adaptation in immune reaction compelled forcibly by the accretion of cholesterol-filled macrophages in the artery wall [1] . Atherosclerosis-related cardiovascular and cerebrovascular (CV) cases are the causal agent resulting in death in rather 50 % of cases in developed countries [2] . The existence of atherosclerotic disease in more than one arterial system can be linked to a higher risk of repeated symptoms and complications. The rates of myocardial infarction, stroke, vascular death or rehospitalization are almost 25.5 % for patients with symptomatic disease in one vascular system and 40.5 % for multiple vascular systems [3] . The constituent lipids of the human body include the most parts of phospholipids, cholesterol, TG and cholesteryl esters, which are carried through blood forming lipoprotein complexes of lipids and one or more proteins, called apolipoproteins, and are under an uninterrupted synthesis/degradation turnover. Low density lipoprotein (LDL) is the product of metabolism of very low density lipoprotein (VLDL), and LDL is built by 75 % lipid (cholesteryl esters and cholesterol) and remaining 25 % protein. Increased LDL levels are connected to cardiovascular disease [4] . Dyslipidemia are known to come from the interactions between genetics and environmental (particularity diet, exercise and tobacco smoking) factors in different populations. The biological, genetics and diet risk factors are likely to account for the diversity in the CAD risk in a number of populations. Several factors appear in the diet that can interpolate the lipids density including the high concentration of lipids as well as a low intake of vegetables and fruits [5] . Apolipoprotein B (Apo B) is significant for the sustainment of cholesterol homeostasis, and is the main protein element of LDL. It acts as the ligand for the identification and catabolism of plasma LDL by LDL-receptor [6] . The increasing levels of serum apo B are associated with an increased risk of premature atherosclerosis [7] . Apo B circulates in two separate forms (Apo B100 and Apo B48), encoded by a single gene confined or restricted to chromosome 2 p23-25. Apo B100, the larger form, is synthesized in the liver as a translational product of the entire apo B mRNA [8] . Various polymorphisms in the Apo B gene have been distinguished, and the rest have been linked to TC, LDL cholesterol, high density cholesterol (HDL) and VLDL cholesterol levels [9] [10] [11] [12] [13] . The Apo B gene is known to have several sequences which are the identification places for various restriction enzymes. Polymorphism in the Apo B gene in regard with the EcoR1 restriction site exists because of a change in guanidine to adenine at exon 29, resulting in the exchange for glutamine for lysine at position 4154 in the Apo B polypeptide product [14] . This nucleotide modification resulting in the loss of the EcoR1 restriction site. The wild type and the mutated alleles are assigned as R? and R-, respectively. The frequency of the R-allele has been shown to be more dominant in CAD patients as in comparison with normal subjects in some, but not all populations; hence, indicating that subjects having the R-allele are more likely to be amenable to CAD development [15] [16] [17] [18] [19] [20] . Several researchers reported the positive connection between the R-allele with elevated serum lipid levels [19] , compared to others suggesting no such link [18] Iranian are believed to have a fat-rich diet and genetically have more tendency to CAD development. The present study would help describe a subset population with a higher or lower risk of CAD. To the knowledge of the researcher, no such study has been carried out on the Iranian population so far.
Material and Methods

Study Population
We recruited 80 CAD? Subjects (31 men and 49 women) with a median age of 60.75 years old and 77 control Subjects (51 men and 26 women) without ischemia or arterial injury with a median age of 55.6 years old at the Mousavi hospital in Zanjan-Iran, The CAD? group included patients with having at least one coronary vessel narrowing 50 % or greater in diameter. The CAD-group included individuals with angiographically normal coronaries and presenting non-signs of CHD upon clinical or laboratory Measurements. The consent form was signed by all participants in the study. This study was approved by the Ethics Committee of the Zanjan University of Medical Sciences.
Measurement of Biochemical Tests
After 12-h overnight fasting, 5 ml whole blood was collected from all subjects without anticoagulant and the serum was used for biochemical analysis. High-density lipoprotein (HDL) was isolated from serum by sedimentation LDL and very low density lipoprotein (VLDL) with magnesium chloride and sodium phosphotungstate chemical agent [21] . TC, TG and HDL cholesterol serum levels were calculated by using an accessible kit from Pars Azmoon Co., Iran (via Hitachi system 717). The LDL cholesterol levels were estimated from the formula given by Friedwald et al. [22] . Serum Apo B levels were measured by an immunoturbidimetric kit.
Genotyping
Two millilitre venous blood were taken for DNA extraction in EDTA. DNA was isolated from leukocytes using spin column (Bioron Co. Germany). DNA sequence containing Apo B gene was amplified by pcr using set of primers (Takapozist, Iran), pcr products electrophoresed on 2 % agarose gel and a fragments of 480 bp containing EcoR1 restriction site was observed for each individual. PCR condition was as follow: 0. 
Results
The baseline characteristics of study subjects are shown in Table 1 . The two groups were well equalized and compared for age and sex. The patients in the case group were older than the control and male to female ratio was higher in the CAD? group significantly. The difference in positive exercise test, history of STEMI, history of blood pressure, and history of stable anginas was significant. Left ventricular dysfunction was revealed by left ventricular ejection fraction and abnormal cardiac. MRI was also more severe in the CAD? group than the control. Also, high blood sugar level was more common in those with significant CAD? than normal subjects. Concerning laboratory parameters, the CAD? group had higher mean value of lipid profile including TC, TG, LDL, VLDL and Apo B serum level while mean HDL was higher in the control group. The findings of the G12889A polymorphism as well as the genotype distribution for Apo B polymorphism are shown in Table 2 . There were two genotypes of the polymorphism in CAD? and CAD-groups with no remarkable difference in the frequency of these genotypes across the two groups. The subjects under study had either the R?R? genotype or R?R-genotype. No individual with homozygous mutant alleles, i.e., R-R-was identified (Fig. 1) . When the R?/R-genotype was compared between the study groups, statistical significance was observed in Apo B, LDL and cholesterol level (P \ 0.05) among CAD? and CAD-participants. Highlighted differences also seen in mean BMI (kg/m 2 ) (P \ 0.05) between CAD? and CAD-participants with the R?/R-genotype (Table 3) .
Multivariable logistic regression analysis (Table 4) showed that among all baseline variables, male gender, progressed age and higher level of fasting blood sugar could foretell the appearance of coronary atherosclerosis. However, the types of the genotypes of 12669G[A polymorphism could not predict CAD. 
Discussion
The role of the Apo B gene polymorphism (12669G[A) in the present study, was investigated in Iranian subjects suffering from CAD and only two genotypes R?R? and R?R-were observed in both control subjects and CAD patients. The R-R-genotype was not seen. The occurrence of this genotype in other populations has been reported to differ from sporadic to nil [8] . In our study, no important connection was observed between the appearance of CAD and gene polymorphism. Also, in a study in the Italian population which compared 55 Italian patients to 117 control patients, the allele frequencies at EcoRI (E) sites did not differ between groups [23] . Similar results have been reported in the Brazilian population [18, 24] , Marshal et al. [25] and also in South Asian subjects living in Britain [17] . On the other hand, remarkable positive connections in the frequency of the R-allele and CAD has been reported in other population [15, 16, 26, 27] . Being incompatible with other studies, in our population Apo B serum levels was remarkably higher in individuals with the R?Rgenotype. A number of Apo B polymorphisms have been found to be linked to serum lipoprotein levels in many children and adult populations [28, 29] . In fact, genetic polymorphisms at the Apo B have been associated with elevated plasma concentrations of LDL cholesterol, and hence, it has been conjectured to be also linked to atherosclerosis and increased risk for CAD [30] . In the present study, we observed higher levels of LDL and cholesterol in individuals with the R?R-genotype in comparison with those having the R?R? genotype. In a study on the Austrian population, the level of serum lipids was higher in the individuals carrying the R?R-Apo B genotype [26] while insignificant difference in lipid profile with different Apo B genotypes has been reported in the other populations [15-17, 23, 24] . 
